Bridgeway Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28K | Buy |
+25,000
| New | +$28K | ﹤0.01% | 1154 |
|
|
2018
Q2 | – | Sell |
-202,000
| Closed | -$1.97M | – | 1429 |
|
|
2018
Q1 | $1.97M | Sell |
202,000
-54,000
| -21% | -$527K | 0.02% | 596 |
|
|
2017
Q4 | $1.56M | Hold |
256,000
| – | – | 0.02% | 666 |
|
|
2017
Q3 | $1.01M | Buy |
256,000
+6,000
| +2% | +$23.8K | 0.01% | 841 |
|
|
2017
Q2 | $810K | Hold |
250,000
| – | – | 0.01% | 903 |
|
|
2017
Q1 | $1.14M | Hold |
250,000
| – | – | 0.01% | 766 |
|
|
2016
Q4 | $628K | Hold |
250,000
| – | – | 0.01% | 988 |
|
|
2016
Q3 | $780K | Sell |
250,000
-144,537
| -37% | -$451K | 0.01% | 903 |
|
|
2016
Q2 | $671K | Sell |
394,537
-80,000
| -17% | -$136K | 0.01% | 928 |
|
|
2016
Q1 | $854K | Buy |
474,537
+250,000
| +111% | +$450K | 0.01% | 831 |
|
|
2015
Q4 | $757K | Buy |
224,537
+130,100
| +138% | +$439K | 0.01% | 882 |
|
|
2015
Q3 | $503K | Buy |
94,437
+57,437
| +155% | +$306K | 0.01% | 1022 |
|
|
2015
Q2 | $239K | Buy |
+37,000
| New | +$239K | ﹤0.01% | 1315 |
|